Brief: Helix Biopharma Retains U.S. Legal And Capital Firms To Advise On U.S. Listing
17/04/2019 22:25
April 17 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP. RETAINS U.S. LEGAL AND CAPITAL FIRMS
TO
ADVISE ON U.S. LISTING
Source text for Eikon: ID:nGNX8M6ZmS
Further company coverage: HBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020